Lupin has received approval for its Fluoxetine Tablets USP, 10 mg and 20 mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Eli Lilly and company’s (Eli Lilly) Prozac Tablets, 10 mg and 20 mg.
The company’s Fluoxetine Tablets USP, 10 mg and 20 mg, is the generic version of Eli Lilly’s Prozac Tablets, 10 mg and 20 mg. Fluoxetine Tablets, 10 mg and 20 mg, (RLD: Prozac) had annual sales of approximately $68.2 million in the US (IQVIA MAT December 2018).
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
